KEW Group
Cambridge
About KEW Group
KEW Group is a personalized oncology management company that provides DNA based genomic testing and interpretation services. It will deploy proprietary oncology therapeutic pathways and personalized medicine tools, including genetic and genomic information, in the community oncology care setting, enabling the highest quality clinical care, efficiently delivered. It was founded in 2009 and is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $32.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2015)
- Website: kewinc.com
- Phone: 617-945-7922
Industries & Categories
Biotechnology, Genetics, Medical Device, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kew-group-2243087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.